For example, Werynska et al. [48] report enhanced MT2A isoform expression in a studied population of non-small cell lung cancer cases, and identify a positive association between MT immunostaining and primary tumor size, grade of malignancy and poor prognosis. This evidence concerns the gene MT2A and non-small cell lung carcinoma.